By applying innovative medicinal chemistry and its unique protein conformation detection technology, Quanta aims to advance two differentiated, next-generation RAS programs that address the resistance paradigms of targeted therapy in oncology.

Source: https://forextv.com/top-news/quanta-therapeutics-announces-two-late-breaking-preclinical-presentations-from-kras-inhibitor-pipeline-at-annual-aacr-meeting/

Canada Pension Plan Investment Board acquired a new position in shares of Quanta Services, Inc. () in the third quarter, reports.

Source: https://www.americanbankingnews.com/2023/02/24/canada-pension-plan-investment-board-invests-10-44-million-in-quanta-services-inc-nysepwr.html

Finally, Korea Investment CORP acquired a new position in shares of Quanta Services during the 2nd quarter worth approximately $5,766,000.

Source: https://www.etfdailynews.com/2023/01/02/cambridge-investment-research-advisors-inc-trims-stock-position-in-quanta-services-inc-nysepwr/